Prof. Ferda KALEAĞASIOĞLU, MD

Also available in: Türkçe

I am graduated from Istanbul University Cerrahpaşa Faculty of Medicine in 1984. After performing my compulsory service as a general physician at Alanya Tuberculosis Control Dispensary in 1984-1986, I completed my medical pharmacology specialty training at Cerrahpaşa Faculty of Medicine in 1991. I joined various research projects on cancer pharmacology at German Cancer Research Center in Germany (1988-1996). At the University of Istanbul, I was involved in the establishment of “Antineoplastic Drugs Research & Development Laboratory” at the Department of Basic Oncology Oncology Institute and the Department of Molecular Medicine at Istanbul University Aziz Sancar Experimental Medicine (formerly Experimental Medicine and Research Institute) (1991-1995). In 1996, I moved to the pharmaceutical industry where I held managerial positions at multinational companies, as Scientific Project Manager, Country R&D Manager, Medical Affairs and Registration Departments’ Manager, Company Spokesperson, Management Committee Member, and Europe-Middle East-Asia Medical Affairs Committee Member; I managed 12 national and international multicenter clinical phase trials. In 2011, I re-started working as an academician at Near East University Faculty of Medicine, Yeditepe University Department of Genetics and Biotechnology and Faculty of Medicine (Phase 3 Coordinator and member in Research Education Development Committee, Research Strategies Committee, Assessment & Evaluation Standardization Groups / Educational Resources Committee). I visited “Institute for Genomics and Systems Biology/ The University of Chicago” as an observer in 2012. For my on-going scientific projects, I am collaborating with German Cancer Research Center / Germany (2013-), School of Advanced International Studies on Applied Theoretical and non Linear Methodologies of Physics/University of Bari (2011- ), Department of Genetics and Biotechnology/ Faculty of Engineering, Yeditepe University (2014- ). My scientific fields of interest are screening of anticancer effects of novel molecules and investigating their mechanisms of actions by tissue culture and experimental animal models in various cancer types, drug toxicity, application of quantum mechanics on autonomic nervous system and cognition, and neurodegenerative diseases.